View Resume/Cv - University of Pennsylvania LDI CHI | Center for ...

UNIVERSITY OF PENNSYLVANIA – PERELMAN SCHOOL OF MEDICINE 

Curriculum Vitae 

Andrea Beth Troxel, Sc.D. 

Office Address: Center for Clinical Epidemiology and Biostatistics 

Telephone: (215) 573-0659 

FAX: (215) 573-4865 

University of Pennsylvania, School of Medicine 

632 Blockley Hall, 423 Guardian Drive 

Philadelphia, Pennsylvania 19104-6021 

E-mail: atroxel@mail.med.upenn.edu 

Education: 

1991 B.S. Yale University (Applied Mathematics) cum laude 

1995 Sc.D. Harvard School of Public Health (Biostatistics) 

Postgraduate Training and Fellowship Appointments: 

October, 2012 

1995 – 1997 Postdoctoral Fellow and Statistical Research Associate, Southwest Oncology 

Group, Fred Hutchinson Cancer Research Center, Seattle, Washington 

Military Service: None 

Faculty Appointments: 

1997 – 2000 Assistant Professor of Clinical Public Health, Herbert Irving Comprehensive 

Cancer Center, Division of Biostatistics, Mailman School of Public Health, 

Columbia University, New York, NY 

2000 – 2003 Assistant Professor of Biostatistics, Department of Biostatistics, Mailman 

School of Public Health, Columbia University, New York, NY 

2003 – 2006 Assistant Professor of Biostatistics at the Hospital of the University of 

Pennsylvania, Department of Biostatistics and Epidemiology, University of 

Pennsylvania School of Medicine 

2006 – 2011 Associate Professor of Biostatistics at the Hospital of the University of 

Pennsylvania, Department of Biostatistics and Epidemiology, University of 


2011 – present Professor of Biostatistics at the Hospital of the University of Pennsylvania, 

Department of Biostatistics and Epidemiology, University of Pennsylvania 

School of Medicine

Troxel, Andrea B., Sc.D. 2 

Hospital and Administrative Appointments: 

2003 – present Member, Graduate Group in Epidemiology and Biostatistics, Biomedical 

Graduate Studies Program, University of Pennsylvania School of Medicine 

2003 – present Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University 

of Pennsylvania School of Medicine 

2008 – present Director of Biostatistics, Leonard Davis Institute Center for Health Incentives 

and Behavioral Economics, University of Pennsylvania School of Medicine 

2011 – present Associate Fellow, Center for Health Behavior Research, University of 


2011 – present Associate Director for Faculty Affairs, Division of Biostatistics, Department of 

Biostatistics and Epidemiology, University of Pennsylvania School of Medicine 

2012 – present Investigator, Center for Pharmacoepidemiology Research and Training, 

University of Pennsylvania School of Medicine 

Specialty Certification: n/a 

Licensure: n/a 

Awards, Honors and Membership in Honorary Societies: 

1991 – 1993 National Institutes of Health Training Grant 

1992 – 1994 Harvard University Teaching Fellow 

2002 – 2006 Sigma Xi 

2006 Circulation Best Paper Award in Population Science, for Stettler, N., Stallings 

V.A., Troxel A.B., Zhao J., Schinnar R., Nelson S.E., Ziegler E.E. and Strom 

B.L. Weight gain in the first week of life and overweight in adulthood: a cohort 

study of European-American subjects fed infant formula. Circulation, 111: 

1897-903, 2005. 

2008 – 2009 Fellow, Columbia University Institute for Scholars at Reid Hall, Paris, France 

2010 British Medical Journal Group Award for “Getting Research Into Practice,” for 

Volpp K.G., Troxel A.B., Pauly M.V., Glick H.A., Puig A., Asch D.A., Galvin 

R., Zhu J., Wan F., DeGuzman J., Corbett E., Weiner J. and Audrain-McGovern 

J. A randomized, controlled trial of financial incentives for smoking cessation. 

New England Journal of Medicine, 360: 699-709, 2009. 

2010 Society of General Internal Medicine Research Paper of the Year, for Volpp 

K.G., Troxel A.B., Pauly M.V., Glick H.A., Puig A., Asch D.A., Galvin R., Zhu 

J., Wan F., DeGuzman J., Corbett E., Weiner J. and Audrain-McGovern J. A 

randomized, controlled trial of financial incentives for smoking cessation. New 

England Journal of Medicine, 360: 699-709, 2009. 

2010 The National Psoriasis Foundation Top Research Findings for 2010, Mehta 

N.N., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B. and Gelfand J.M. 

Patients with severe psoriasis are at increased risk of cardiovascular mortality: 

Cohort study using General Practice Research Database. European Heart

Troxel, Andrea B., Sc.D. 

Journal, 31: 1000-6, 2010. 

2010 The National Psoriasis Foundation Top Research Findings for 2010, Kurd 

S.K., Troxel A.B., Crits-Christoph P. and Gelfand J.M. The risk of depression, 

anxiety and suicidality in patients with psoriasis: A population-based cohort 

study. Archives of Dermatology, 146: 891-5, 2010. 

2010 Excellence in Teaching Epidemiology Award, Center for Clinical Epidemiology 

and Biostatistics, University of Pennsylvania School of Medicine 

2012 Elected Fellow, American Statistical Association 

Membership in Professional and Scientific Societies and Other Professional Activities: 

International: 

1996 Member, Workshop on Missing Data in Quality of Life Research in Cancer 

Clinical Trials: Practical and Methodological Issues, Swiss Group for Clinical 

Cancer Research 

1999 – present International Biometrics Society 

National: 

1997 Member, Phase II Clinical Trials of New Chemopreventive Agents, NIH Review 

Panel and Board, NCI 

1999 – present Member, American Statistical Association 

2001 Member, Minimally Invasive Surgical Therapies for Benign Prostatic 

Hypertrophy, NIH Review Panel and Board, NIDDK 

2002 – 2004 Member, Chronic Prostatitis Collaborative Research Network (CPCRN), 

External Advisory Committee, NIDDK 

2003 Member, Avon/NCI Progress for Patients Award Program 

2005 – 2006 Ad hoc member, Biostatistical Methods and Research Design study section, 

Health of Populations IRG, NIH 

2005 Ad hoc member, Developmental Therapeutics study section, Oncological 

Sciences IRG, NIH 

2005 Ad hoc member, Subcommittee E (Cancer Epidemiology, Prevention and 

Control), National Cancer Institute IRG, NIH 

2005 – 2009 Ad hoc member, Epidemiology of Cancer (EPIC) study section, Health of 

Populations IRG, NIH 

2007 – present Chair, Data and Safety Monitoring Board, DAIDS-ES 10401 (Antiviral Activity 

of Peg-IFN-a-2A in Chronic HIV-1 Infection; L. Montaner, PI) 

2008 – 2012 Member, Blood Products Advisory Committee, Food and Drug Administration 

2008 – present Member, Data and Safety Monitoring Board, Terumo Heart DH-003 (Evaluation 

of the Safety and Effectiveness of the DuraHeart Left Ventricular Assist System 

in Patients Awaiting Transplantation) 

2009 – 2011 Member, EPIC Member Conflict Special Emphasis Panel (ZRG1 PSE-B 03 M) 

3


2010 Member, Education Advisory Committee, ENAR 

2010 – 2011 Ad hoc member, Cancer Biomarkers study section, Oncology 2 – Translational 

Clinical IRG, NIH 

2011 – present Chair, Data and Safety Monitoring Board, PNAT (Pharmacogenetics of Nicotine 

Addiction Treatment; C. Lerman, PI) 

2011 – present Chair, TREC Randomized Clinical Trials Methods Working Group 

Local: 

2004 – 2009 Member, Data and Safety Monitoring Board, UPCC 11102/03104 (R. 

Vonderheide, PI) 

2004 – present Member, Philadelphia Chapter, American Statistical Association 

2009 – 2011 Member, Scientific Monitoring Committee, UPCC 08107 (R. Vonderheide, PI) 

2009 – present Member, Safety Monitoring Committee, UPCC 05609 (R. Vonderheide, PI) 

2009 – 2011 Chair, Data and Safety Monitoring Board, Smart Steps/Mind 

Your Body (N. Stettler, PI) 

2011 – present Member, Safety Monitoring Committee, UPCC 03111 (R. Vonderheide, PI) 

2011 – present Member, Data and Safety Monitoring Board, UPCC 14211 (R. Vonderheide, PI) 

Editorial Positions: 

1998 – present Reviewer Applied Statistics 

1998 – present Reviewer Biometrics 

1998 – present Reviewer Journal of the American Medical Women’s Association 

1998 – present Reviewer Journal of Clinical Oncology 

1998 – present Reviewer Journal of the American Statistical Association 

1999 – present Reviewer American Journal of Public Health 

1999 – present Reviewer Quality of Life Research 

1999 – present Reviewer Statistics in Medicine 

2000 – present Reviewer Communication in Statistics 

2000 – present Reviewer Controlled Clinical Trials 

2002 – present Reviewer Biometrical Journal 

2005 – present Reviewer Fertility and Sterility 

2005 – present Associate Editor Statistics in Medicine 

2006 – present Reviewer Journal of the National Cancer Institute 

2006 – present Reviewer Scandinavian Journal of Statistics 

2007 – present Reviewer Journal of Clinical Investigation 

2007 – present Reviewer Journal of Biopharmaceutical Statistics 

2007 – present Reviewer Pharmacoepidemiology and Drug Safety 

2008 – present Reviewer Journal of the Royal Statistical Society, Series B


2010 – present Reviewer Biostatistics 

2010 – present Reviewer Computational Statistics and Data Analysis 

2011 – present Associate Editor BMC Medical Research Methodology 

2012 – present Statistical Editor Journal of Clinical Oncology 

Academic and Institutional Committees: 

2003 – 2008 

Member, Admissions Committee, Division of Biostatistics, Department of 


2004 – 2006 Member (Chair, 2005-2006), Curriculum Committee, Division of Biostatistics, 


School of Medicine 

2004 – present 

(on leave 

2008 – 2009) 

Member, Appointments Committee, Center for Clinical Epidemiology and 

Biostatistics, University of Pennsylvania School of Medicine 

2005 Member, Summer Fellowship Committee, Center for Clinical Epidemiology and 

Biostatistics, University of Pennsylvania School of Medicine 


(on leave 

2008 – 2009) 

2006 – 2008 



(on leave 

2008 – 2009) 


Chair, Qualifying Examination Committee, Division of Biostatistics, 



Member, Committee on Appointments and Promotions (COAP), Department of 


Member, Gender Equity Council, University of Pennsylvania School of 

Medicine 

Member, Recruitment Committee, Division of Biostatistics, Department of 


2011 – present Member, Committee on Appointments and Promotions (COAP), Department of 


2011 – present Member, Student-Faculty Relations Committee, Division of Biostatistics, 



2011 – 2014 Member, Hearings List, Faculty Grievance Commission, University of 

Pennsylvania 

2012 – present Member, Qualifying Examination Committee, Department of Biostatistics 


2012 – present Member, Graduate Programs Executive Committee, Department of Biostatistics, 


5


Major Academic and Clinical Teaching Responsibilities: 

2003 – 2006 PhD Thesis Committee Member for Jiameng Zhang, Department of Biostatistics 

and Epidemiology, University of Pennsylvania School of Medicine 

2003 – 2006 PhD Thesis Director for Denise A. Esserman, Columbia University Mailman 

School of Public Health 

2004 – 2006 MSCE Thesis Committee Member for Andrea Cheville, MD, Department of 


2004 – 2005 Academic Advisor for Michal Magid-Slav, Department of Biostatistics and 

Epidemiology, University of Pennsylvania School of Medicine 

2004 – 2005 MSCE Thesis Committee Member for Andrew Ochroch, MD, Department of 


2004 – 2006 MSCE Thesis Committee Member for Andrea Neimann, MD, Department of 


2004 – 2008 MSCE Thesis Committee Member for Nananamibia Smith, MD, Department of 


Spring 2004 Instructor, Consulting II (BSTA 691), Department of Biostatistics and 


Fall 2004 Course Director, Applied Regression Models for Categorical Data (EP 622), 



Fall 2004 Course Director, Independent Study: Applied Regression Models for 

Categorical Data (EP 999), Department of Biostatistics and Epidemiology, 


Fall 2004 Lecturer, Unequal Treatment: Health in America (HSOC 015), Health and 

Societies Program, University of Pennsylvania School of Arts and Sciences 

Fall 2004 Lecturer, Independent Study: Ameliorating Health Disparities One Step at a 

Time (HSOC 499.036), Health and Societies Program, University of 

Pennsylvania School of Arts and Sciences 

2005 – 2008 Academic Advisor for Hanjoo Kim, Department of Biostatistics and 


2005 – 2008 MSCE Thesis Committee Member for Noelle Frey, MD, Department of 


Spring 2005 Lecturer, Independent Study: Ameliorating Health Disparities One Step at a 

Time (HSOC 499.036), Health and Societies Program, University of 

Pennsylvania School of Arts and Sciences 

Spring 2005 Lecturer, Undergraduate Urban Research Course (CPLN 528/URBS 428), 

Institute for Urban Research, University of Pennsylvania School of Arts and 

Sciences 

Spring 2005 Instructor, Consulting II (BSTA 691), Department of Biostatistics and 

Epidemiology, University of Pennsylvania School of Medicine


Spring 2005 Facilitator, BGS Bioethics Workshop for 3 rd Year Students, University of 





2006 – 2008 MSCE Thesis Committee Member for Daniel Elliott, MD, Department of 


2006 – 2008 MSCE Thesis Committee Member for Kimberly Forde, MD, Department of 


2006 – 2008 MSCE Thesis Committee Member for Steven Halbert, MD, Department of 


2006 – 2009 MSCE Thesis Committee Member for Chrysalyne Schmults, MD, Department 

of Biostatistics and Epidemiology, University of Pennsylvania School of 

Medicine 

2006 – 2011 Secondary Mentor, Scarlett Bellamy, ScD, Department of Biostatistics and 


Spring 2006 Course Director, Independent Study: Longitudinal Data Analysis (EP 999), 






2007 – 2008 MSCE Thesis Committee Member for Robert Sutton, MD, Department of 


2007 – 2009 MSCE Thesis Committee Member for Shanu Kohli Kurd, MD, Department of 


2007 – present Primary Mentor, Wei-Ting Hwang, PhD, Department of Biostatistics and 


Spring 2007 Lecturer, Clinical Trials (EP 630), Department of Biostatistics and 


Spring 2007 Lecturer, Fundamentals of Pharmacology II (Pharm 623), Department of 

Pharmacology, University of Pennsylvania School of Medicine 

Summer 2007 Lecturer, Advanced Topics in Clinical Epidemiology (EP 640), Department of 





Fall 2007 Course Director, Applied Survival Analysis (EP 623), Department of 


7


2008 MSCE Thesis Committee Member for Stephen Keefe, MD, Department of 


2008 – present PhD Thesis Committee Member for Kimberly Forde, MD, Department of 


Spring 2008 Lecturer, Clinical Trials (EP 630), Department of Biostatistics and 


Spring 2008 Lecturer, Fundamentals of Pharmacology II (Pharm 623), Department of 

Pharmacology, University of Pennsylvania School of Medicine 



2009 – present MSCE Thesis Committee Member for Peter de Blank, MD, Department of 


2009 – 2010 PhD Thesis Co-Director for Seunghee Baek, MS, Department of Biostatistics 


2009 – 2011 Academic Advisor for Cristin Scott, Department of Biostatistics and 





2010 – present MSCE Thesis Committee Member for Alexis Ogdie, MD, Department of 


2010 – 2011 PhD Thesis Committee Member for Steffanie Halberstadt, MS, Department of 


2010 – 2011 PhD Thesis Committee Member for Hong Wan, MS, Department of Biostatistics 


2010 – 2012 PhD Thesis Director for Kaijun Liao, MS, Department of Biostatistics and 


Spring 2010 Lecturer, Applied Regression Analysis for Health Policy Research (HPR 608), 

Master of Science in Health Policy Program, University of Pennsylvania School 

of Medicine 

Spring 2010 Facilitator, Biomedical Graduate Studies Responsible Conduct in Research 

Workshop for 4 th Year Students, University of Pennsylvania School of Medicine 



2011 – present Primary Mentor, Scarlett Bellamy, ScD, Department of Biostatistics and 


2011 – present PhD Thesis Director for Kay-See Tan, MS, Department of Biostatistics and 


2011 – present MSCE Thesis Committee Member for Junko Takeshita, MD, Department of 

Biostatistics and Epidemiology, University of Pennsylvania School of Medicine


2011 – present MSCE Thesis Committee Member for Meera Nair, MD, Department of 


Spring 2011 Course Director, Longitudinal Data Analysis (BSTA 656), Department of 




Spring 2012 Course Director, Longitudinal Data Analysis (BSTA 656), Department of 





2012 – present Academic Advisor for Pixu Shi, Department of Biostatistics and Epidemiology, 


2012 – present MSCE Thesis Committee Member for Ashley Ford, MD, Department of 


2012 – present MSCE Thesis Committee Member for Tamara Miller, MD, Department of 


Lectures by invitation: (past five years only) 

2/28/2005 “Frailty Models for Quality of Life Data in Oncology” – Fred Hutchinson 

Cancer Research Center, Seattle, WA 

3/2/2005 “Modeling Quality of Life Data with Missing Values” – Division of Cancer 

Prevention and Control, National Cancer Institute, Bethesda, MD 

3/5/2005 “Modeling Quality of Life Data with Missing Values” – Connecticut Chapter of 

the American Statistical Association, Wallingford, CT 

8/9/2005 “Frailty Models for Quality of Life Data in Oncology” – Joint Statistical 

Meetings, Minneapolis, MN 

7/29/2007 “Multivariate Normal Frailty Models for Multiple QOL Outcomes” – Joint 

Statistical Meetings, Salt Lake City, UT 

8/3/2008 “Extensions of Frailty Models for Multivariate Grouped Survival Data” – Joint 

Statistical Meetings, Denver, CO 

10/7/2008 “Early Phase Clinical Trials in Oncology” – Columbia University Institute for 

Scholars at Reid Hall, Paris, France 

10/17/2008 “An Index of Sensitivity to Nonignorability” – Ecole Doctorale “Epidémiologie 

Sciences Sociales et Santé Publique,” Villejuif, France 

1/6/2009 “Frailty Models for Quality of Life in Oncology” – Unit 780, Institut National de 

la Santé et de la Récherche Médicale, Villejuif, France 

1/16/2009 “A New Pseudo-Likelihood for Longitudinal Binary Data with Nonignorable 

Missingness” – Interuniversity Institute for Biostatistics and Statistical 

Bioinformatics, Universiteit Hasselt, Diepenbeek, Belgium 

9


2/3/2009 “Pseudo-Likelihood Approaches for Binary Longitudinal Data with 

Nonignorable Missingness” – Unit 897, Institut National de la Santé et de la 

Récherche Médicale, Université Victor Segalen Bordeaux 2, Bordeaux, France 

2/26/2009 “Modeling Quality of Life Data with Missing Values” – Unitat de 

Bioestadística I Bioinformàtica, Institut Català d’Oncologia, Barcelona, Spain 

3/5/2009 “Analysis of Quality of Life Data when Some Responses are Missing” – 

Columbia University Institute for Scholars at Reid Hall, Paris, France 

3/10/2009 “Modeling Quality of Life Data with Missing Values” – International Agency 

for Research on Cancer, Lyons, France 

12/3/2010 “A New Pseudo-Likelihood for Longitudinal Binary Data with Nonignorable 

Missingness” – Department of Statistics, Florida State University, Tallahassee, 

FL 

4/13/2011 “New Incentive Approaches for Adherence” – Department of Biostatistics, 

University of Pennsylvania, Annual Conference on Statistical Issues in Clinical 

Trials, Philadelphia, PA 

Organizing roles in Scientific Meetings: 

3/1999 ENAR meeting, Organized Invited Session 45, “New Developments in Analysis 

of Quality of Life in Clinical Trials,” Atlanta, GA 

8/14/2002 JSM, Organized Invited Session 340, “Sensitivity Analysis for Longitudinal 

Data,” New York, NY 

8/9/2005 JSM, Organized Topic Contributed Session 309, “Analyzing Quality of Life 

Data in Clinical Trials,” Minneapolis, MN 

Bibliography: 

Research publications, peer reviewed: 

1. Gribben J.G., Neuberg D., Freedman A.S., Pesek K., Troxel A.B. and Nadler L.M.: 

Detection of residual lymphoma cells by PCR in peripheral blood is significantly less 

predictive for relapse than evaluation of bone marrow. Blood 80: 337, 1992. 

2. Saphner T., Troxel A.B., Tormey D.C., Neuberg D., Robert N.J., Pandya K.J., 

Edmonson J.H., Rosenbluth R.J. and Abeloff, M.D.: Phase II study of goserelin for 

patients with postmenopausal metastatic breast cancer. Journal of Clinical Oncology 

11: 1529-1535, 1993. 

3. Bennett J.M., Troxel A.B., Gelman R., Falkson G., Coccia-Portugal M.D., Dreicer 

R., Tormey D.C. and Rushing D.: Myelodysplastic syndrome and acute myeloid 

leukemia secondary to mitolactol treatment in patients with breast cancer. Journal of 

Clinical Oncology 12: 874-875, 1994. 

4. Ramsey S.D., Etzioni R., Troxel A.B. and Urban N.: Optimizing sampling strategies 

for estimating quality-adjusted life years. Medical Decision Making 17: 431-438, 

1997.


5. Troxel A.B., Lipsitz S.R. and Brennan T.A.: Weighted estimating equations with 

nonignorably missing response data. Biometrics 53: 857-869, 1997. 

6. Monipour C.M., Savage M.J., Troxel A.B., Lovato L.C., Eisenberger M., Veith R.B., 

Higgins B., Skeel R., Yee M., Blumenstein B., Crawford E.D. and Meyskens F.L.: 

Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. 

Journal of the National Cancer Institute 90: 1537-1544, 1998. 

7. Troxel A.B.: A comparative analysis of quality of life data from a Southwest 

Oncology Group randomized trial of advanced colorectal cancer. Statistics in 

Medicine 17: 767-779, 1998. 

8. Troxel A.B., Fairclough D.L., Curran D. and Hahn E.A.: Statistical analysis of 

quality of life with missing data in cancer clinical trials. Statistics in Medicine 17: 

653-666, 1998. 

9. Troxel A.B., Harrington D.P. and Lipsitz S.R.: Analysis of longitudinal data with 

non-ignorable non-monotone missing values. Applied Statistics 74: 425-438, 1998. 

10. Troxel A.B., Lipsitz S.R. and Harrington D.P.: Marginal models for the analysis of 

longitudinal measurements with nonignorable non-monotone missing data. 

Biometrika 85: 661-672, 1998. 

11. Grann V.R., Jacobson J.S., Sundararajan V., Albert S.M., Troxel A.B. and Neugut 

A.I.: The quality of life associated with prophylactic treatment for women with 

BRCA1/2 mutations. Cancer Journal from Scientific American 5: 283-292, 1999. 

12. Kambham N., Taylor J.A., Troxel A.B. and Rubin M.A.: Atypical small acinar 

proliferation in prostate needle biopsies: a clinically significant category. Journal of 

Urologic Pathology 10: 177-179, 1999. 

13. Papadopoulos K.P., Ayello J., Reiss R.F., Troxel A., Kaufman E., Vahdat L.T., 

Antman K.H. and Hesdorffer C.S.: CD34+ cell dose requirements for rapid 

engraftment in a sequential high dose chemotherapy regimen of paclitaxel, 

melphalan and cyclophosphamide, thiotepa and carboplatin (CTCb) with PBPC 

support in metastatic breast cancer. Journal of Hematotherapy and Stem Cell 

Research 8: 357-363, 1999. 

14. Papadopoulos K.P., Balmaceda C., Fetell M., Kaufman E., Vahdat L.T., Bruce J., 

Sisti M., Isaacson S., DeLaPaz R., Savage D.G., Troxel A., Antman K.H. and 

Hesdorffer C.S.: A Phase I study of BCNU, etoposide, and escalating-dose thiotepa 

(BTE) with hematopeietic progenitor cell support in adults with recurrent and highrisk 

brain tumors. Journal of Neurooncology 44: 155-162, 1999. 

11


15. Rowe D.R., Huang J., Kayton M.L., Thompson R., Troxel A., O'Toole K.M., 

Yamashiro D., Stolar C.J.H. and Kandel J.: Anti-VEGF antibody suppresses primary 

tumor growth and metastasis in an experimental model of Wilms' tumor. Journal of 

Pediatric Sugery 35: 30-33, 2000. 

16. Brenin D.R., Manasseh D.M., El-Tamer M., Troxel A., Schnabel F., Ditkoff B.A. 

and Kinne D.: Factors correlating with lymph node metastases in patients with T1 

breast cancer. Annals of Surgical Oncology 8: 432-437, 2001. 

17. Jacbson J.S., Troxel A.B., Evans J., Klaus L., Vahdat L.T., Kinne D., Lo K.M., 

Moore A., Rosenman P.J., Kaufman E.L., Neugut A.I. and Grann V.R.: Randomized 

trial of black cohosh for the treatment of hot flashes among women with a history of 

breast cancer. Journal of Clinical Oncology 19: 2739-2745, 2001. 

18. Ovchinnikov I., Troxel A.B. and Swergold G.D.: Genomic characterization of recent 

human LINE-1 insertions: evidence supporting random insertion. Genome Research 

11: 2050-2058, 2001. 

19. Papadopoulos K.P., Gorin M.J., Huang M., Troxel A.B., Kaufman E., Balmaceda 

C.M., Vahdat L.T. and Hesdorffer C.S.: The pharmacokinetics and 

pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous 

infusion over 24h) with hematopoietic support in women with metastatic breast 

cancer. Cancer Chemotherapy Pharmacology 47: 45-60, 2001. 

20. Nichols G., deCastro K., Wei L.X., Griffin M., Lin M., Oratzi A., Murty A.V.V.S., 

Troxel A., Vahdat L. and Hesdorffer C.: Therapy-related myelodysplastic syndrome 

after autologous stem cell transplantation for breast cancer. Leukemia 16: 1673-1679, 

2002. 

21. Troxel A.B.: Techniques for incorporating longitudinal measurements into analyses 

of survival data from clinical trials. Statistical Methods in Medical Research 11: 237- 

245, 2002. 

22. Vahdat L.T., Balmaceda C., Papadopoulos K., Frederick D., Donovan D., Sharpe E., 

Kaufman E., Savage D., Tiersten A., Nichols G., Haythe J., Troxel A., Antman K. 

and Hesdorffer C.S.: Phase II trial of sequential high-dose chemotherapy with 

paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with 

peripheral blood progenitor support in women with responding metastatic breast 

cancer. Bone Marrow Transplantation 30(3): 149-155, 2002. 

23. El-Tamer M., Komenaka I., Curry S., Troxel A.B., Ditkoff B.A. and Schnabel F.R.: 

Pulse oximeter changes with sentinel lymph node biopsy in breast cancer. Archives 

of Surgery 138: 1257-1260, 2003.


24. Hershman D., Weinberg M., Rosner Z., Alexis K., Tiersten A., Grann V.R., Troxel 

A. and Neugut A.I.: Ethnic neutropenia and treatment delay in African American 

women undergoing chemotherapy for early-stage breast cancer. Journal of the 

National Cancer Institute 95: 1545-1548, 2003. 

25. Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A.B., Rosen J., Eskeline 

E.L., Mizushima N., Ohsumi Y., Cattoetti G. and Levine B.: Promotion of 

tumorigenesis by heterozygous disruption of the beclin1 autophagy gene. Journal of 

Clinical Investigation 11: 1809-1820, 2003. 

26. Talbot S.M., Keohan M.L., Hesdorffer M., Orrico R., Bagiella E., Troxel A.B., and 

Taub R.N.: A Phase II trial of temozolomide in patients with unresectable or 

metastatic soft tissue sarcoma. Cancer 98: 1942-1946, 2003. 

27. Tiersten A.D., Nelson C., Talbot S., Vahdat L., Fine R., Troxel A., Brafman L., 

Shriberg L., Antman K. and Petrylak D.P.: A Phase II trial of docetaxel and 

estramustine in patients with refractory metastatic breast carcinoma. Cancer 97: 537- 

544, 2003. 

28. El-Tamer M., Russo D., Troxel A., Bernadino L.P., Mazziotta R., Estabrook A., 

Ditkoff B.A. Schnabel R. and Mansukhani, M.: Survival and recurrence after breast 

cancer in BRCA/2 mutation carriers. Annals of Surgical Oncology 11: 157-164, 

2004. 

29. El-Tamer M.B., Komenaka I.K., Troxel A., Li H., Joseph K.A., Ditkoff B.A., 

Schnabel F.R. and Kinne D.W.: Men with breast cancer have better disease-specific 

survival than women. Archives of Surgery 139: 1079-1082, 2004. 

30. Joseph K.A., El-Tamer M., Komenaka I., Troxel A., Ditkoff B.A., Schnabel F.: 

Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel 

node metastasis. Archives of Surgery 139: 648-351, 2004. 

31. Komenaka S.K., El-Tamer M.B., Troxel A., Hamele-Bena D., Joseph K.A., 

Horowitz E., Ditkoff B.A. and Schnabel R.: Pure mucinous carcinoma of the breast. 

American Journal of Surgery 187: 528-532, 2004. 

32. Tiersten A., Ng Y.Y., Pile-Spellman E., Nelsen C., Noguera-Irizarry W., Brafman R., 

Russo D., Troxel A. and Johnson A.: Relationship between mammographic breast 

density and tamoxifen in women with breast cancer. Breast Journal 10: 313-317, 

2004. 

33. Tiersten A., Wo J., Jacobson C., Weitzman A., Horwich T., Hesdorffer C., Savage D. 

and Troxel A.: Cardiac toxicity observed in association with high-dose 

cyclophosphamide-based chemotherapy for metastatic breast cancer. Breast 13: 341- 

346, 2004. 

13


34. Tiersten A.D., Selleck M.J., Hershman D.L., Smith D., Resnik E.E., Troxel A.B., 

Brafman L.B. and Shriberg L.: Phase II study of topotecan and paclitaxel for 

recurrent, persistent or metastatic cervical carcinoma. Gynecologic Oncology 92: 

635-638, 2004. 

35. Troxel A.B. and Esserman D.A.: Frailty models for quality of life in oncology. 

Journal of Biopharmaceutical Statistics 14: 145-154, 2004. 

36. Troxel A.B., Ma G. and Heitjan D.F.: An index of sensitivity to nonignorability 

Statistica Sinica 14: 1221-1237, 2004. 

37. Grann V.R., Jacobson J.S., Karp J., Hershman D., Troxel A.B., Myers K. and 

Neugut A.I.: Barriers to minority participation in breast cancer prevention trials. 

Cancer 104: 374-379, 2005. 

38. Grann V.R., Troxel A.B., Zojwalla N., Jacobson J.S., Hershman D. and Neugut A.I.: 

Hormone receptor status and survival in a population-based cohort of patients with 

breast cancer. Cancer 103: 2241-2251, 2005. 

39. Joe A.K., Memeo L., McKoy J., Mansukhani M., Liu H., Avila-Bront A., Romero J., 

Li H., Troxel A. and Hibshoosh H.: Cyclin D1 overexpression is associated with 

estrogen receptor expression in Caucasian but not African-American breast cancer. 

Anticancer Research 25: 273-281, 2005. 

40. Ma G., Troxel A.B. and Heitjan D.F.: An index of local sensitivity to nonignorable 

dropout in longitudinal modeling. Statistics in Medicine 24: 2129-2150, 2005. 

41. Park J.H., Gopishetty S., Szewczuk L.M., Troxel A.B., Harvey R.G. and Penning 

T.M.: Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) by PAH oquinones: 

involvement of reactive oxygen species and copper(II)/copper(I) redox 

cycling. Chemical Research in Toxicology 18: 1026-1037, 2005. 

42. Stettler N., Stallings V.A., Troxel A.B., Zhao J., Schinnar R., Nelson S.E., Ziegler 

E.E. and Strom B.L.: Weight gain in the first week of life and overweight in 

adulthood: a cohort study of European-American subjects fed infant formula. 

Circulation 111: 1897-903, 2005. 

43. Stubblefield M.S., Vahdat L.T., Balmaceda C.M., Troxel A.B., Hesdorffer C.S. and 

Gooch C.L.: Glutamine as a neuroprotective agent in high-dose paclitaxel-induced 

peripheral neuropathy: a clinical and electrophysiologic study. Clinical Oncology 17: 

271-276, 2005.


44. Brown T.T., Quain R.D., Troxel A.B. and Gelfand J.M.: The epidemiology of 

sunburn in the U.S. population in 2003. Journal of the American Academy of 

Dermatology 55: 577-583, 2006. 

45. Clark J., Lambertson C., Gelfand R. and Troxel A.: Optimization of oxygen tolerance 

extension in rats by intermittent exposure. Journal of Applied Physiology 100: 869- 

879, 2006. 

46. Fisher J.A., Fikry C.R. and Troxel A.B.: Cutting cost and increasing access to 

colorectal cancer screening: another approach to following the guidelines. Cancer 

Epidemiology, Biomarkers and Prevention 15: 108-113, 2006. 

47. Gelfand J.M., Neimann A.L., Shin D.B., Wang X., Margolis D.J. and Troxel A.B.: 

The risk of myocardial infarction in patients with psoriasis. Journal of the American 

Medical Association 296: 1735-1741, 2006. 

48. Gelfand J.M., Shin D.B., Neimann A.L., Wang X., Margolis D.J. and Troxel A.B.: 

The risk of lymphoma in patients with psoriasis. Journal of Investigative 

Dermatology 126: 2194-2201, 2006. 

49. Gorin S.S., Ashford A.R., Lantigua R., Hossain A., Desai M., Troxel A., Neugut A.I. 

and Gemson D.: Effectiveness of academic detailing on breast cancer screening 

among primary care physicians in an underserved community. Journal of the 

American Board of Family Medicine 19: 110-121, 2006. 

50. Grann V.R., Troxel A.B., Jacobson J.S., Zojwalla N., Hershman D., Glied S.A. and 

Neugut, A.I.: Regional and racial disparities in breast cancer-specific and all-cause 

mortality. Social Science and Medicine 62: 337-347, 2006. 

51. Jacobson J.S., Grann V.R., Hershman D., Troxel A.B., Li H. and Neugut A.I.: Breast 

biopsy and race/ethnicity among women without breast cancer. Cancer Detection and 

Prevention 30: 129-133, 2006. 

52. Ma G., Troxel A.B. and Heitjan D.F.: Author's reply. Statistics in Medicine 25: 

3218-3220, 2006. 

53. Neimann A.N., Shin D.B., Wang X., Margolis D.J., Troxel A.B. and Gelfand J.M.: 

Prevalence of cardiovascular risk factors in patients with psoriasis. Journal of the 

American Academy of Dermatology 55: 829-835, 2006. 

54. Ochroch E.A., Troxel A.B. and Farrar J.T.: Women suffer more short and longterm 

pain than men after major thoracotomy. Journal of Clinical Pain 22: 491-498, 2006. 

15


55. Park J-H., Troxel A.B., Harvey R.G. and Penning T.M.: PAH o-quinones produced 

by the Aldo-Keto-Reductases (AKRs) generate abasic sites, oxidized pyrimidines 

and 8-oxo-dGuo via reactive oxygen species. Chemical Research in Toxicology 19: 

719-728, 2006. 

56. Parzen M., Lipstiz S.R., Fitzmaurice G.M., Ibrahim J.G. and Troxel A.: Pseudolikelihood 

methods for longitudinal binary data with non-ignorable missing 

responses and covariates. Statistics in Medicine 25: 2784-2796, 2006. 

57. Rebbeck T.R., Troxel A.B., Wan Y., Walker A.H., Panossian S., Gallagher S., 

Shatalova E.G, Blanchard R.M, Bunin G., DeMichele A., Rubin S.C., Baumgarten 

M., Berlin M., Schinnar R., Berlin J.A. and Strom B.L.: Estrogen sulfation genes, 

hormone replacement therapy, and endometrial cancer risk. Journal of the National 

Cancer Institute 98: 1311-1120, 2006. 

58. Shen Y-M., Troxel A.B., Vedantam S., Penning T.M. and Field J.: Comparison of 

p53 mutations inducted by PAH o-quinones with those caused by antibenzo[a]pyrene 

diol epoxide in vitro: role of reactive oxygen and biological 

selection. Chemical Research in Toxicology 19: 1441-1450, 2006. 

59. Strom B.L, Schinnar R, Weber A.L, Bunin G.R., Berlin J.A., Baumgarten M., 

DeMichele A.M., Rubin S., Troxel A.B. and Rebbeck T.A.: Protective effect of 

postmenopausal use of combined estrogen plus progestin hormone therapy on 

endometrial cancer risk. American Journal of Epidemiology 165: 778-786, 2006. 

60. Brauer J.A., Shin D.B, Troxel A.B., Shapiro M., Levy M. and Ming M.E.: 

Characteristics of dermatologists who read dermatopathology slides. Journal of 

Cutaneous Pathology 34: 687-692, 2007. 

61. Clark L.N., Shin D.B., Troxel A.B., Khan S., Sober A.J. and Ming M.E.: 

Association between the anatomic distribution of melanoma and sex. Journal of the 


62. Gelfand J.M., Kurd S.K., Neimann A.L., Shin D.B., Margolis D.J. and Troxel, A.B.: 

Psoriasis and the risk of myocardial infarction -‐ reply. Journal of the American 


63. Gelfand J.M., Troxel A.B., Lewis J.D., Kurd S.K., Shin D.B., Wang X., Margolis 

D.J. and Strom B.L: The risk of mortality in patients with psoriasis: Results from a 

population-based study. Archives of Dermatology 143: 1493-1499, 2007. 

64. Gorin S.S., Ashford A.R., Lantigua R., Desai M., Troxel A. and Gemson D.: 

Implementing academic detailing for breast cancer screening in underserved 

communities. Implementation Science 2: 43, 2007.


65. Klein R.Q., Teal V., Taylor L., Troxel A.B. and Werth V.P.: Number, 

characteristics, and classification of patients with dermatomyositis seen by 

dermatology and rheumatology departments at a large tertiary medical center. 

Journal of the American Academy of Dermatology 57: 937-943, 2007. 

66. Ochroch E.A., Troxel A.B., Frogel J.K. and Farrar J.T: The influence of race and 

socioeconomic factors on patient acceptance of perioperative epidural analgesia 

Anesthesia and Analgesia 105: 1787-1792, 2007. 

67. Parzen M., Lipsitz S.R., Fitzmaurice G.M., Ibrahim J.G., Troxel A. and Molenberghs 

G.: Pseudo-likelihood methods for the analysis of longitudinal binary data subject to 

nonignorable non-monotone missingness. Journal of Data Science 5: 1-21, 2007. 

68. Rebbeck T.R., Troxel A.B., Norman S., Bunin G.R., DeMichele A., Baumgarten M., 

Berlin M., Schinnar R. and Strom B.L: A retrospective case-control study of the use 

of hormone-related supplements and association with breast cancer. International 

Journal of Cancer 120: 1523-1528, 2007. 

69. Rebbeck T.R., Troxel A.B., Norman S., Bunin G.R., DeMichele A., Schinnar R., 

Berlin J. and Strom B.: Pharmacogenetic modulation of combined hormone 

replacement therapy by progesterone-metabolism genotypes in postmenopausal 

breast cancer risk. American Journal of Epidemiology 166: 1392-1399, 2007. 

70. Rebbeck T.R., Troxel A.B., Shatalova E.G., Blanchard R., Norman S., Bunin G., 

DeMichele A., Baumgarten M., Berlin M., Schinnar R., Berlin J.A. and Strom B.L.: 

Lack of effect modification between estrogen metabolism genotypes and combined 

hormone replacement therapy in post-menopausal breast cancer risk. Cancer 

Epidemiology, Biomarkers, and Prevention 16: 1318-1320, 2007. 

71. Rebbeck T.R., Troxel A.B., Walker A.H., Panossian S., Gallagher S., Shatalova 

E.G., Blanchard R., Norman S., Bunin G., DeMichele A., Baumgarten M., Berlin M., 

Schinnar R., Berlin J.A. and Strom B.L: Pairwise combinations of estrogen 

metabolism genotypes in post menopausal breast cancer etiology. Cancer 

Epidemiology Biomarkers, and Prevention 16: 444-450, 2007. 

72. Vahdat L.T., Cohen D.J., Zipin D., Lo K.S., Donovan D., Savage D., Tiersten A., 

Nichols G., Troxel A. and Hesdorffer C.S.: Randomized trial of low-dose 

interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy 

with peripheral blood progenitor support in women with high-risk primary breast 

cancer. Bone Marrow Transplantation 40: 267-272, 2007. 

73. Bonilla-Martinez Z.L., Albrecht J., Troxel A.B., Taylor L., Okawa J., Dulay S. and 

Werth V.P.: The cutaneous lupus erythematosus disease area and severity index: a 

responsive instrument to measure activity and damage in patients with cutaneous 

lupus erythematosus. Archives of Dermatology 144: 173-180, 2008. 

17


74. Cheville A.L., Troxel A.B., Basford J.R. and Kornblith A.B.: Prevalence and 

treatment patterns of physical impairments in patients with metastatic breast cancer. 

Journal of Clinical Oncology 26: 2621-29, 2008. 

75. DeMichele A., Troxel A.B., Berlin J.A., Weber A.L., Bunin G.R., Turzo E., 

Schinnar R., Burgh D., Berlin M., Rubin S.C., Rebbeck T.R. and Strom B.L.: Impact 

of raloxifene or tamoxifen use on endometrial cancer risk: a population-based casecontrol 

study. Journal of Clinical Oncology 26: 4151-4159, 2008. 

76. Farrar J.T., Troxel A.B., Stott C., Duncombe P. and Jensen M.P.: Validity, 

reliability, and clinical importance of change in a 0-10 numeric rating scale measure 

of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled 

trial. Clinical Therapeutics 30: 974-985, 2008. 

77. Gaines E., Bonilla-Martinez Z., Albrecht J., Taylor L., Okawa J., Troxel A.B. and 

Werth V.P.: Quality of life and disease severity in a cutaneous lupus erythematosus 

pilot study. Archives of Dermatology 144: 1062-2, 2008. 

78. Gupta-Abramson V., Troxel A.B., Nellore A., Puttaswamy K., Redlinger M., 

Ransone K., Mandel S.J., Flaherty K.T., Loevner L.A., O'Dwyer P.J. and Brose 

M.S.: Phase II trial of sorafenib in advanced thyroid cancer. Journal of Clinical 

Oncology 26: 4714-4719, 2008. 

79. Hormes J.M., Lytle L.A., Gross C.R., Ahmed R.L., Troxel A.B. and Schmitz K.H.: 

The body image and relationships scale: development and validation of a measure of 

body image in female breast cancer survivors. Journal of Clinical Oncology 26: 

1269-1274, 2008. 

80. Klein R.Q., Bangert C.A., Costner M., Connolly M.K., Tanikawa A., Okawa J., Rose 

M., Fakharzadeh S.S., Fiorentino D., Lee L.A., Sontheimer R.D., Taylor L., Troxel 

A.B. and Werth V.P.: Comparison of the reliability and validity of outcome 

instruments for cutaneous dermatomyositis. British Journal of Dermatology 159: 

887-894, 2008. 

81. Krathan M., Dunham J., Gaines E., Junkins-Hopkins J., Kim E., Kolasinksi S., 

Kovarik C., Kwan-Morley J., Okawa J., Propert K., Rogers N., Rose M., Thomas P., 

Troxel A., Van Vorhees A., Von Feldt J., Weber A. and Werth V.: The cutaneous 

lupus erythematosus disease activity and severity index (CLASI) expansion for 

rheumatology and dermatology. Arthritis Care and Research 59: 338-344, 2008. 

82. Kurd S.K., Smith N., VanVorhees A., Troxel A.B., Badmaev V., Seykora J.T. and 

Gelfand J.M.: Oral curcumin in the treatment of moderate to severe psoriasis 

vulgaris: a prospective clinical trial Journal of the American Academy of 

Dermatology 58: 625-631, 2008.


83. Lewis J.D, Gelfand J.M., Troxel A.B., Forde K.A., Newcomb C., Kim H., Margolis 

D.J. and Strom B.L.: Immunosuppressant medications and mortality in inflammatory 

bowel disease. American Journal of Gastroenterology 103: 1428-1435, 2008. 

84. Mirza N., Machtay M., Devine P.A., Troxel A., Abboud S.K. and Doty R.L.: 

Gustatory impairment in patients undergoing head and neck irradiation. 

Laryngoscope 118: 24-31, 2008. 

85. Park J.-H., Gelhaus S., Vedantam S., Oliva A., Batra A., Blair I., Troxel A., Field J. 

and Penning T.: The pattern of p53 mutations caused by PAH o-quinones is driven 

by 8-oxo-dGuo formation while the spectrum of mutations is determined by 

biological selection for dominance. Clinical Research in Toxicology 21: 1039-49, 

2008. 

86. Volpp K.G., John L.K., Troxel A.B., Norton L., Fassbender J. and Loewenstein G.: 

Financial incentive-based approaches for weight loss: a randomized trial. Journal of 

the American Medical Association 300: 2631-2637, 2008. 

87. Volpp K.G., Loewenstein G., Troxel A.B., Doshi J., Price M., Laskin M. and 

Kimmel S.E.: A test of financial incentives to improve warfarin adherence. BMC 

Health Services Research 8: 272, 2008. 

88. Yoon J.S., Newton S.M., Wysocka M., Troxel A.B., Hess S.D., Richardson S.K., 

Lin J.H., Benoit B.M., Kasprzycka M., Wasik N.A. and Rook A.H.: IL-21 enhances 

antitumor responses without stimulating proliferation of malignant T cells of patients 

with Sezary syndrome. Journal of Investigative Dermatology 128: 473-480, 2008. 

89. Amaravadi R.K., Schuchter L.M., McDermott D.F., Kramer A., Giles L., Gramlich 

K., Carberry M., Troxel A.B., Letrero R., Nathanson K.L., Atkins M.B., O'Dwyer 

P.J. and Flaherty K.T.: Phase II trial of temozolomide and sorafenib in advanced 

melanoma patients with or without brain metastases. Clinical Cancer Research 15: 

7711-8, 2009. 

90. Bacik P.R., Carton A.K., Zhang C., Troxel A.B. and Maidment A.D.: Breast percent 

density: Estimation on digital mammograms and central tomosynthesis projections. 

Radiology 252: 40-49, 2009. 

91. Cheville A.L., Basford J.L, Troxel A.B. and Kornblith A.B.: Performance of 

common clinician- and self-report measures in assessing the function of community 

dwelling people with metastatic breast cancer. Archives of Physical Medicine and 

Rehabilitation 90: 2116-24, 2009. 

92. Elliott D.J., Zaoutis T.E., Troxel A.B., Loh A. and Keren R.: Empiric antimicrobial 

therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant 

Staphylococcus aureus. Pediatrics 123: 959-966, 2009. 

19


93. Forde K.A., Reddy K.R., Troxel A.B., Sanders C.M. and Lee W.M.: Racial and 

ethnic differences in presentation, etiology, and outcomes of acute liver failure in the 

United States. Clinical Gastroenterology and Hepatology 7: 1121-26, 2009. 

94. Gelfand J.M, Dommasch E.D., Shin D.B., Azfar R.S., Kurd S.K., Wang X. and 

Troxel A.B.: The risk of stroke in patients with psoriasis. Journal of Investigative 

Dermatology 129: 2411-18, 2009. 

95. Kontos D., Bakic P.R., Carton A.K., Troxel A.B., Conant E.F. and Maidment A.D.: 

Parenchymal texture analysis in digital breast tomosynthesis for breast cancer risk 

estimation: A preliminary study. Academic Radiology 16: 283-98, 2009. 

96. Nellore A., Paziana K., Ma C., Tsygankova O.M., Wang Y., Puttaswamy K., Iqbal 

A.U., Franks S.R., Lv Y., Troxel A.B., Feldman M.D., Meinkoth J.L. and Brose 

M.S.: Loss of Rap1GAP in papillary thyroid cancer. Molecular Endocrinology 23: 

277, 2009. 

97. Rebbeck T.R., DeMichele A., Tran T.V., Panossian S., Bunin G.R., Troxel A.B. and 

Strom B.L.: Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer 

susceptibility in a population-based sample of post-menopausal African-American 

and European-American women. Carcinogenesis 30: 269-74, 2009. 

98. Rosenbach M., Murrell D.F., Bystryn J.C., Dulay S., Dick S., Farkharzadeh S., Hall 

R., Korman N.J., Lin J., Okawa J., Pandya A.G., Payne A.S., Rose M., Rubenstein 

D., Woodley D., Vittorio C., Werth B.B., Williams E.A., Taylor L., Troxel A.B. and 

Werth V.P.: Reliability and convergent validity of two outcome instruments for 

pemphigus. Journal of Investigative Dermatology 129: 2404-10, 2009. 

99. Ross A.S., Whalen F.M., Elenitsas R., Xu X., Troxel A.B. and Schmults C.D.: 

Diameter of involved nerves predicts outcomes in cutaneous squamous cell 

carcinoma with perineural invasion: An investigator-blinded retrospective cohort 

study. Dermatologic Surgery 35: 1859-66, 2009. 

100.Schmitz K.H., Ahmed R.L., Troxel A., Cheville A., Smith R., Lewis-Grant L., 

Bryan C.J., Williams-Smith C.T. and Greene Q.A.: A randomized trial of weight 

lifting among women with breast cancer-related lymphedema. New England Journal 

of Medicine 361: 664-73, 2009. 

101. Schmitz K.H., Troxel A.B., Cheville A., Grant L.L., Bryan C.J., Gross C.R., Lytle 

L.A. and Ahmed R.L.: Physical activity and lymphedema (the PAL trial): Assessing 

the safety of progressive strength training in breast cancer survivors. Contemporary 

Clinical Trials 30: 233-245, 2009.


102. Volpp K.G., Troxel A.B., Pauly M.V., Glick H.A., Puig A., Asch D.A., Galvin R., 

Zhu J., Wan F., DeGuzman J., Corbett E., Weiner J. and Audrain-McGovern J.: A 

randomized, controlled trial of financial incentives for smoking cessation. New 

England Journal of Medicine 360: 699-709, 2009. 

103. Abramson V.G., Troxel A.B., Feldman M., Mies C., Wang Y., Sherman L., 

McNally S., Diehl A. and DeMichele A.: Cyclin D1b in human breast carcinoma 

and coexpression with cyclin D1a is associated with poor outcome. Anticancer 

Research 30: 1279-85, 2010. 

104. Abuabara K., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B. and Gelfand J.M.: 

Cause-specific mortality in patients with severe psoriasis: A population-based 

cohort study in the United Kingdom. British Journal of Dermatology 163: 586-92, 

2010. 

105. Brauer J.A., Wriston C.C., Troxel A.B., Elenitsas R., Shin D.B., Guerry D. and 

Ming M.E.: Characteristics associated with early and late melanoma metastases. 

Cancer 116: 415-23, 2010. 

106. Dommasch E., Shin D.B., Troxel A.B., Margolis D.J. and Gelfand J.M.: Reliability, 

validity, and responsiveness to change of the Patient Report of Extent of Psoriasis 

Involvement (PREPI) for measuring body surface area affected by psoriasis. British 

Journal of Dermatology 162: 835-42, 2010. 

107. Halbert C.H., Coyne J., Weathers B., Mahler B., Delmoor E., Vaughn D., 

Malkowicz S.B., Lee D. and Troxel A.B.: Racial differences in quality of life 

following prostate cancer diagnosis. Urology 76: 559-64, 2010. 

108. Halbert C.H., Kessler L., Troxel A.B., Stopfer J.E. and Domchek S.: Effect of 

genetic counseling and testing for BRCA1 and BRCA2 mutations in African 

American women: A randomized trial. Public Health Genomics 13: 440-8, 2010. 

109. Hormes J.M., Bryan C., Lytle L.A., Gross C.R., Ahmed R.L., Troxel A.B. and 

Schmitz K.H.: Impact of lymphedema and arm symptoms on quality of life in breast 

cancer survivors. Lymphology 43: 1-13, 2010. 

110. Kurd S.K., Gelfand J.M., Crits-Cristoph P. and Troxel A.B.: The risk of depression, 

anxiety, and suicidality in patients with psoriasis: A population-based cohort study. 

Archives of Dermatology 146: 891-5, 2010. 

111. Mehta N.N., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B. and Gelfand J.M.: 

Patients with severe psoriasis are at increased risk of cardiovascular mortality: A 

cohort study using the General Practice Research Database. European Heart Journal 

31: 1000-6, 2010. 

21


112. Schmitz K.H., Ahmed R.L., Troxel A., Cheville A., Lewis-Grant L., Smith R., 

Bryan C.J., Williams-Smith C.T. and Chitthams J. Weight lifting for women at risk 

for breast cancer-related lymphedema: a randomized trial. Journal of the American 


113. Spiotta A.M., Stiefel M.F., Gracias V.H., Garuffe A.M., Kofke W.A., Maloney- 

Wilensky E., Troxel A.B., Levine J.M. and Le Roux P.D.: Brain tissue oxygendirected 

management and outcome in patients with severe traumatic brain injury. 

Journal of Neurosurgery 113: 571-80, 2010. 

114. Thom S.R., Bhopale V.M., Milovanova T.M., Hardy K.R., Logue C.J., Lambert 

D.S., Troxel A.B., Ballard K. and Eisinger D.: Plasma biomarkers in carbon 

monoxide poisoning. Clinical Toxicology 48: 47-56, 2010. 

115. Troxel A.B., Lipsitz S.R., Fitzmaurice G.M., Ibrahim J.G., Sinha D. and 

Molenberghs G.A.: A weighted combination of pseudo-likelihood estimators for 

longitudinal binary data subject to non-ignorable non-monotone missingness. 

Statistics in Medicine 29: 1511-21, 2010. 

116. Yassaee M., Fiorentino D., Okawa J., Taylor L., Coley C., Troxel A.B. and Werth 

V.P.: Modification of the Cutaneous Dermatomyositis Disease Area and Severity 

Index, an outcome instrument. British Journal of Dermatology 162: 669-73, 2010. 

117. Dommasch E.D., Abuabara K., Shin D.B., Nguyen J., Troxel A.B. and Gelfand 

J.M.: The risk of infection and malignancy with tumor necrosis factor antagomists 

in adult patients with psoriatic disease: A systematic review and meta-analysis of 

randomized controlled trials. Journal of the American Academy of Dermatology 

64(6): 1035-50, 2011. 

118. Evans K.G., Troxel A.B., DeNardo B.J., Introcaso C.E., Rook A.H. and Kim E.J. : 

Validity assessment of the cutaneous T-cell lymphoma severity index to predict 

prognosis in advanced mycosis fungoides/Sezary syndrome. Journal of the 

American Academy of Dermatology 64(4): 682-9, 2011. 

119. Halbert C.H., Barg F.K., Guerra C.E., Shea J.A., Armstrong K., Ferguson M., 

Weathers B., Coyne J. and Troxel A.B.: Cultural, economic, and psychological 

predictors of colonoscopy in a national sample. Journal of General Internal 

Medicine 26(11): 1311-6, 2011. 

120. Halbert C.H., Stopfer J.E., McDonald J., Weathers B., Collier A., Troxel A.B. and 

Domchek S. : Long-term reactions to genetic testing for BRCA1 and BRCA2 

mutations: Does time heal women's concerns? Journal of Clinical Oncology 29: 

4302-6, 2011.


121. John L.K., Loewenstein G., Troxel A.B., Norton L., Fassbender J.E. and Volpp 

K.G.: Financial incentives for extended weight loss: A randomized, controlled trial. 

Journal of General Internal Medicine 26(6): 621-6, 2011. 

122. Klein R., Maghadam-Kia S., Lomonico J., Okawa J., Coley C., Taylor L., Troxel 

A.B. and Werth V.P.: Development of the CLASI as a tool to measure disease 

severity and responsiveness to therapy in cutaneous lupus erythematosus. Archives 

of Dermatology 147(2): 203-8, 2011. 

123. Kontos D., Ikejimba L.C., Bakic P.R., Troxel A.B., Conant E.F. and Maidment 

A.D.A.: Analysis of parenchymal texture with digital breast tomosynthesis: 

Comparison with digital mammography and implications for cancer risk assessment. 

Radiology 26(1): 80-91, 2011. 

124. Mehta N.N., Yu Y., Pinnelas R., Krishnamoorthy P., Shin D.B., Troxel A.B., and 

Gelfand J.M.: Attributable risk estimate of severe psoriasis on major cardiovascular 

events. American Journal of Medicine 124(8): 775.e1-6, 2011. 

125. Seminara N.S., Abuabara K., Shin D.B., Langan S.M., Kimmel S.E., Margolis D., 

Troxel A.B., and Gelfand J.M.: Validity of the health improvement network (THIN) 

for the study of psoriasis. British Journal of Dermatology 164(3): 602-9, 2011. 

126. Sinha S.K., Troxel A.B., Lipsitz S.R., Sinha D., Fitzmaurice G.M., Molenberghs 

G., Ibrahim J.G.: A bivariate pseudo-likelihood for incomplete longitudinal binary 

data with nonignorable non-monotone missingness. Biometrics 67(3): 1119-26, 

2011. 

127. Wysocka M., Dawany N., Benoit B., Kossenkov A.V., Troxel A.B., Gelfand J.M., 

Sell M.K., Showe L.C. and Rook A.H. : Synergistic enhancement of cellular 

immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferongamma: 

implications for therapy of cutaneous T-cell lymphoma. Leukemia & 

Lymphoma 52(10): 1970-9, 2011. 

128. Abuabara K., Wan J, Troxel A.B., Shin D.B., Van Voorhees A.S., Bebo B.F., 

Krueger G.G., Callis Duffin K., and Gelfand J.M.: Variation in dermatologist beliefs 

about the safety and effectiveness of treatments for moderate-to-severe psoriasis. 

Journal of the American Academy of Dermatology 2012, In press. 

129. Azfar R.S., Seminara N.M., Shin D.B., Troxel A.B., Margolis D.J., Gelfand J.M.: 

Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus 

treatment in patients with psoriasis. Archives of Dermatology, 148:995-1000, 2012. 

23


130. Brown J.C., Troxel A.B. and Schmitz K.H.: Safety of weightlifting among women 

with or at risk for breast cancer-related lymphedema: Musculoskeletal injuries and 

health care use in a weightlifting rehabilitation trial. The Oncologist, 17:1120-8, 

2012. 

131. Forde K.A., Haynes K., Troxel A.B., Trooskin S., Osterman M.T., Kimmel S.E., 

Lewis J.F. and Lo Re V.: Risk of myocardial infarction associated with chronic 

hepatitis C virus infection: A population-based cohort study. Journal of Viral 

Hepatitis, 19, 2012. 

132. Gelfand J.M., Wan J., Callis Duffin K., Krueger G.G., Kalb R.E., Weisman J.D., 

Sperber B.R., Stierstorfer M.B., Brod B.A., Schleicher S.M., Bebo B.F. Jr, Troxel 

A.B., Shin D.B., Steinemann J.M., Goldfarb J., Yeung H. and Van Voorhees A.S.: 

Comparative effectiveness of commonly used systemic treatments or phototherapy 

for moderate to severe plaque psoriasis in the clinical practice setting. Archives of 

Dermatology 148(4): 487-94, 2012. 

133. Kimmel S.E. and Troxel A.B.: Novel incentive-based approaches to adherence. 

Journal of the Society for Clinical Trials 2012, In press. 

134. Kimmel S.E., Troxel A.B., Loewenstein G., Brensinger C.M., Jaskowiak J., Doshi 

J.A., Laskin M. and Volpp K.: Randomized trial of lottery-based incentives to 

improve warfarin adherence. American Heart Journal 164(2): 268-74, 2012. 

135. Langan S.M., Seminara N.M., Shin D.B., Troxel A., Kimmel S.E., Mehta N.N., 

Margolis D.J. and Gelfand J.M.: Prevalence of metabolic syndrome in patients with 

psoriasis: A population-based study in the United Kingdom. Journal of Investigative 

Dermatology 132: 556-62, 2012. 

136. Liao K., Freres D. and Troxel A.B.: A transition model for quality of life data with 

non-ignorable non-monotone missing data Statistics in Medicine 2012, In press. 

137. McDonald J.A., Barg F., Weathers B., Guerra C., Troxel A.B., Domchek S., Bowen 

D., Shea J. and Halbert C.H.: Understanding African American participation in 

cancer genetics research. Journal of the National Medical Association 2012, In 

press. 

138. McDonald J.A., Weathers B., Barg F.K., Troxel A.B., Shea J.A., Bowen D., Guerra 

C.E. and Halbert C.H.: Donation intentions for cancer genetics research among 

African Americans. Genetic Testing and Molecular Biomarkers 16: 252-8, 2012. 

139. Mehta N.N., Krishnamoorthy P., Yu Y., Khan O., Raper A., Van Voorhees A., 

Troxel A.B. and Gelfand J.M.: The impact of psoriasis on 10-year Framingham 

risk. Journal of the American Academy of Dermatology 67: 796-8, 2012.


140. Speck R.M., Sammel M.D., Troxel A.B., Cappola A.R., Williams-Smith C.T., 

Chittams J., Scott P., Tuton L.W.and Abbuhl S.B.: Factors impacting the departure 

rate of female and male junior medical school faculty: Evidence from a longitudinal 

analysis. Journal of Women's Health 21(10): 1059-65, 2012 

141. Troxel, A.B., Volpp, K.G.: Effectiveness of financial incentives for longer-term 

smoking cessation: Evidence of absence or absence of evidence? American Journal 

of Health Promotion 26(4): 204-7, 2012. 

142. Wan J., Abuabara K., Shin D.B., Troxel A.B., Bebo B.F. and Gelfand J.M.: 

Dermatologist response rates to a mailed questionnaire: a randomized trial of 

monetary incentives. Journal of the American Academy of Dermatology 66(1): e18- 

20, 2012. 

143. Wan J., Abuabara K., Troxel A.B., Shin D.B., Van Vorhees A.S., Bebo B.F., 

Kruger G.G., Duffin K.C. and Gelfand J.M.: Dermatologist preferences for first-line 

therapy of moderate to severe psoriasis in healthy adult patients. Journal of the 


144. Wan J., Abuabara, K., Troxel A.B., Shin D.B., Van Voorhees A.S., Bebo B.F. Jr., 

Kruger G.G., Duffin K.C., and Gelfand J.M.: Dermatologist preferences for 

treatments to compare in future randomized controlled comparative effectiveness 

trials for moderate to severe psoriasis. Archives of Dermatology 148(4): 539-41. 

2012. 

145. Yeung H., Wan J., Van Voorhees A.S., Callis-Duffin K., Krueger G.G., Kalb R.E., 

Weisman J.D., Sperber B.R., Brod B.A., Bebo F., Schleicher S.M., Shin D.B., 

Troxel A.B. and Gelfand J.M. : Patient-reported reasons for the discontinuation of 

commonly used treatments for moderate-to-severe psoriasis. Journal of the 

American Academy of Dermatology 2012, In press. 

Research Publications: peer-reviewed reviews: 

None 

Contributions to peer-reviewed clinical research publications, participation cited but not by 

authorship: None 

Research publications, non-peer reviewed: 

1. Troxel, A.B. and Blumenstein, B. Time to event (TTE) methods as a way of analyzing 

quality of life (QOL) and/or symptom data. American Statistical Association, Proceedings of 

the Biopharmaceutical Section 73-8, 1997. 

Abstracts: (past three years only) 

25


1. Abuabara K., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B. and Gelfand J.M.: 

Cause-specific mortality in patients with severe psoriasis: A cohort study using the 

general practice research database. (oral presentation). Society of Investigative 

Dermatology 2009. 

2. Azfar R.S., Neimann A.L., Shin D.B., Troxel A.B. and Gelfand J.M.: Risk of 

cardiovascular mortality in patients with severe psoriasis. (poster presentation). Society 

for Investigative Dermatology 2009. 

3. Brose M.S., Troxel A.B., Redlinger M., Harklacker K., Redlinger C., Chalian A.A., 

Flaherty K.T., Loevner L.A., Mandel S.J. and O'Dwyer P.J.: Effect of BRAF v600E on 

response to sorafenib in advanced thyroid cancer patients. (poster presentation). 

American Society of Clinical Oncology 2009. 

4. Cetnar J.P., Rosen M.A., Vaughn D.J., Haas N.B., Troxel A.B., Song H., Adluru G., 

Flaherty K.T., O'Dwyer P.J. and Amaravadi R.K.: Phase II study of sorafenib and 

docetaxel in men with metastatic castration resistant prostate cancer (mCRPC). (poster 

presentation). American Society of Clinical Oncology 2009. 

5. Cheville A.L., Basford J., Troxel A.B. and Kornblith A.: Determinants of functional 

disability in stage IV breast cancer. (poster presentation). Society of Clinical Oncology 

2009. 

6. Dommasch E., Shin D., Troxel A.B., Margolis D.J., Chren M.M. and Gelfand J.M.: 

Reliability and validity of the Patient Report of Extent of Psoriasis Involvement 

(PREPI) for determining psoriasis severity. (poster presentation). Society for 

Investigative Dermatology 2009. 

7. Kurd S.K., Troxel A.B. and Gelfand J.M.: The risk of depression in patients with 

psoriasis. (poster presentation). International Society for Pharmacoepidemiology 2009. 

8. Mehta N.N., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B. and Gelfand J.M.: 

Patients with severe psoriasis and no history of cardiovascular disease are at increased 

risk of cardiovascular mortality. (poster presentation). American Heart Association 

2009. 

9. Seminara N., Abuabara K., Shin D., Kimmel S., Margolis D.J., Troxel A.B. and 

Gelfand J.M.: Prevalence of psoriasis severity and predictive value of psoriasis codes 

in The Health Improvement Network (THIN)-‐ a population based study. (oral 

presentation). Society of Investigative Dermatology 2009.


10. Wriston C.C., Troxel A.B., Shin D.B., Schaffer A., Rubin A.I., Brauer J.A. and 

Ming M.E.: Tumor infiltrating lymphocytes are a prognostic marker for survival in 

patients who develop melanoma metastases. (poster presentation). Society of 


11. Baek S., Bellamy S.L., Troxel A.B., Ten Have T.R. and Jemmott J.B.: Extension of 

Max-ID copula to longitudinal binary couples' data. (oral presentation). Joint 

Statistical Meetings 2010. 

12. Baek S., Bellamy S.L., Troxel A.B., TenHave T.R. and Jemmott J.B.: A coupla 

approach for estimating correlation of shared couple behaviors. (poster presentation). 

ENAR Annual Meeting 2010. 

13. Brose M.S., Troxel A.B. and Mamtani R.: Phase II trial of everolimus + sorafenib 

for patients with differentiated thyroid cancer (DTC) who progress on sorafenib alone. 

(oral presentation). ASCO Annual Meeting 2010. 

14. De Blank P.M.K., Zaoutis T., Fisher B., Troxel A.B., Kim J. and Aplenc R.: Risk 

factors for clostridium difficile infection in children with malignancy (oral 

presentation). ASCO Annual Meeting 2011. 

15. Keefe S.M., Troxel A.B., Rhee S., Puttaswamy K., O'Dwyer P.J., Loevner L.A., 

Mandel S.J. and Brose M.S.: Phase II trial of sorafenib in patients with advanced 

thyroid cancer. (oral presentation). ASCO Annual Meeting 2011. 

16. Langan S., Seminara N.M., Troxel A.B., Shin D.B., Margolis, D.J., Kimmel S., 

Mehta N.N. and Gelfand, J.M. : Prevalence of metabolic syndrome in patients with 

psoriasis: A population-based study in the United Kingdom. (oral presentation). 

Society of Investigative Dermatology 2011. 

17. Seminara N.M, Azfar R.S., Shin D.B., Troxel A.B., Margolis D.J. and Gelfand J.M.: 

Patients with psoriasis are at increased risk of diabetes: A population based study. (oral 

presentation). Society of Investigative Dermatology 2011. 

18. Wan J., Abuabara K., Troxel A.B., Shin D.B., Van Voorhees A.S., Bebo B.F. Jr., 

Krueger G.G., Callis Duffin K. and Gelfand J.M.: Dermatologist preferences for firstline 

therapy of moderate-to-severe psoriasis in healthy adults. (poster presentation). 

Society of Investigative Dermatology 2011. 

19. Yu Y., Mehta N.N., Male S., Krishnamoorthy P., Haynes K., Seminara N., Shin D., 

Troxel A.B., Sanford Schwartz J. and Gelfand J.M.: The risk of myocardial infarction 

in patients with psoriasis: results from a large population-based cohort study. (oral 

presentation). American Heart Association Scientific Sessions 2011. 

27


20. Abuabara K., Wan J., Troxel A.B., Shin D.B., Van Vorhees A.S., Bebo B.F., 

Krueger G.G., Duffin K.C. and Gelfand J.M. : Variation in dermatologist beliefs about 

the safety and effectiveness of psoriasis treatments (oral presentation). Society of 


21. Brown J., Schmitz K. and Troxel A.B.: Musculoskeletal injuries in weight lifting 

among women with or at-risk for breast-cancer-related lymphedema. (poster 

presentation). Society of Behavioral Medicine 2012. 

22. Brown J.C., Troxel A.B. and Schmitz K. : Musculoskeletal injuries and healthcare 

needs among women with or at-risk for lymphedema in a weight lifting exercise trial 

(oral presentation). American College of Sports Medicine 2012. 

23. Kimmel S.R., Troxel A.B., Brensinger C., French B., Liu Q., Lowenstein G. and 

Volpp K.G. : A randomized trial of interventions to improve warfarin adherence 

(poster presentation). Institute on Aging Annual Retreat, University of Pennsylvania 

2012. 

24. Ogdie A., Haynes K., Troxel A.B, Love T., Hennessy S., Choi H. and Gelfand J. : 

Mortality in patients with psoriatic arthritis compared to patients with rheumatoid 

arthritis, psoriasis alone, and the general population. American College of 

Rheumatology conference 2012. 

25. Ranganathan A., Schwed-Lustgarten D., Aggarwal C., Werner L., Torigian D.A., 

Troxel A.B., Evans T.L., Stevenson J., Cohen R.B., Vaidya B., Rao C., Connelly 

M.C., Albelda S. and Langer C.J. : Circulating tumor cells (CTCs) in patients with 

small cell lung cancer (SCLC): A marker of disease burden, therapeutic response, and 

predictor of disease relapse (oral presentation). ASCO 2012. 

26. Troxel A.B. and Volpp K.G.: Effectiveness of financial incentives for longer-term 

smoking cessation (poster presentation). Institute on Aging Annual Retreat, University 

of Pennsylvania 2012. 

27. Yeung H., Duffin C.K., Wan J., Troxel A.B., Shin D. and Gelfand J.M. : Patientreported 

reasons for discontinuation of commonly used treatments for moderate to 

severe psoriasis. (oral presentation). Society of Investigative Dermatology 2012. 

28. Troxel A.B.: Mortality in Patients with Psoriatic Arthritis Compared to Patients with 

Rheumatoid Arthritis, Psoriasis Alone, and the General Population (oral presentation). 

ACR/ARHP Annual Meeting 2012. 

Editorials, Reviews, Book Chapters, Including Participation in Committee Reports (print or 

other media: 

1. Troxel A.B. and Moinpour C.M. Statistical analysis of quality of life data. In Handbook of 

Statistics in Clinical Oncology, J. Crowley, ed. New York: Marcel Dekker, Inc., 2001.


2. Troxel A.B. and Moinpour C.M. Design and analysis of quality of life data. In Handbook of 

Statistics in Clinical Oncology, 2 nd ed., J. Crowley and D. Ankerst, eds. Boca Raton: CRC 

Press, Inc. 2005. 

3. Troxel A.B. A review of Missing Data in Clinical Studies, by G. Molenberghs and M. G. 

Kenward. Journal of Biopharmaceutical Statistics, 18: 588-9, 2008. 

4. Troxel A.B. and Moinpour C.M. Design and analysis of quality of life data. In Handbook of 

Statistics in Clinical Oncology, 3 rd ed., J. Crowley and A Hoering, eds. Boca Raton: CRC 

Press, Inc. 2012. 

Books: None 

Alternative Media: None 

Patents: None 

29

View Resume/Cv - University of Pennsylvania LDI CHI | Center for ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?